P/E at 66.05 vs Industry's 66.80: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium or Parity?

The current P/E of Apollo Hospitals Enterprise Ltd. stands at 66.05, marginally below the hospital industry average of 66.80. This near equivalence suggests that the market values the company in line with its sector peers, reflecting neither a significant premium nor a discount. Given the company’s large-cap status with a market capitalisation of ₹1,29,823.17 crores, this valuation level indicates investor confidence in its earnings quality and growth prospects relative to the hospital sector. The close alignment with the industry P/E also implies that valuation alone may not be the primary driver of recent price action — previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in the valuation premium.

Performance Across Timeframes: Consistent Outperformance

Examining the stock’s returns reveals a consistent pattern of outperformance versus the Sensex across all key periods. Over one year, Apollo Hospitals gained 20.21%, while the Sensex declined by 3.97%. The three-month return of 18.19% dwarfs the Sensex’s modest 1.37% gain, signalling strong momentum in the medium term. Year-to-date, the stock has surged 28.21%, contrasting sharply with the Sensex’s 8.52% loss. Even over longer horizons, the stock’s performance is impressive: a 74.44% gain over three years, 123.80% over five years, and a remarkable 564.21% over ten years, compared to the Sensex’s respective returns of 17.19%, 48.26%, and 177.93%. This sustained alpha generation highlights the company’s resilience and growth trajectory in the hospital sector.

Moving Average Configuration: Bullish Technical Setup

The technical picture for Apollo Hospitals Enterprise Ltd. is notably positive. The stock is trading above all major moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a strong uptrend across short, medium, and long-term horizons. This comprehensive bullish configuration is reinforced by the stock hitting a new 52-week and all-time high of ₹9,099.95 on 31 July 2026. The stock has also recorded five consecutive days of gains, accumulating a 3.36% return during this period, and outperformed its sector by 0.71% on the day. Such momentum suggests robust investor demand and technical strength, is this a genuine recovery or a relief rally that will fade at the 50 DMA? The moving average configuration provides the clearest answer.

Sector Performance Context: Hospital Industry Trends

The hospital sector has experienced mixed results recently, with a combination of positive, flat, and negative performances among its constituents. Against this backdrop, Apollo Hospitals stands out as a consistent outperformer. Its ability to maintain a valuation close to the sector average while delivering superior returns suggests operational strength and market leadership. The stock’s outperformance relative to the sector on both daily and longer-term bases underscores its resilience amid sector volatility. This dynamic raises the question: should investors in Apollo Hospitals hold, buy more, or reconsider?

Rating Reassessment: From Hold to a New Evaluation

On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from a previous Hold rating. While the current rating is not disclosed, the reassessment reflects a comprehensive review of the company’s fundamentals, valuation, and technical outlook. The previous Mojo Score of 75.0 and the large-cap market cap grade provide a strong foundation for this evaluation. The data-driven approach behind the rating change considers the stock’s consistent outperformance, near-parity valuation, and bullish moving average configuration, offering a nuanced perspective on its investment profile.

Conclusion: A Data-Driven Portrait of Strength

The data for Apollo Hospitals Enterprise Ltd. reveals a stock trading at a valuation almost identical to its sector peers, yet delivering markedly superior returns across all major timeframes. Its technical setup is robust, with the stock trading above all key moving averages and hitting new all-time highs. The hospital sector’s mixed performance further accentuates the company’s relative strength. The recent rating reassessment from Hold reflects these factors, though the current rating remains undisclosed. Taken together, these data points provide a comprehensive view of a large-cap hospital stock that continues to demonstrate resilience and growth — what is the current rating for Apollo Hospitals Enterprise Ltd.?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →